About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clinical Trials in Arizona | 16,770 Studies Near You | Clareo Health

Clinical Trials LocationsArizona

Clinical Trials in Arizona

Discover 16,770 clinical trials near Arizona. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Filters

Sort by

Status

Recruiting(Enrolling)

Not yet recruiting

Active, not recruiting

Enrolling by invitation(Enrolling)

Completed

Terminated

Phase

Early Phase 1

Phase 1

Phase 1/Phase 2

Phase 2

Phase 2/Phase 3

Phase 3

Phase 4

Not Applicable

Eligibility

Accepts healthy volunteers

Showing 15221-15240 of 16,770 trials

COMPLETEDPhase 231 miles

A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)

NCT01281631

This is a Phase 2 randomized, double-blind, placebo-controlled, multicenter study of NP001 in subjects with ALS.

Amyotrophic Lateral Sclerosis

Neuraltus Pharmaceuticals, Inc.136 participantsStarted Feb 2011

Scottsdale, Arizona, United States • Irvine, California, United States • Los Angeles, California, United States +14 more locations

COMPLETEDPhase 331 miles

Ramelteon in Adults With Chronic Insomnia

NCT00671567

The purpose of this study is to determine the safety and efficacy of Ramelteon, once daily (QD), in adult subjects with chronic insomnia.

Chronic Insomnia

Takeda848 participantsStarted Dec 2002

Birmingham, Alabama, United States • Mobile, Alabama, United States • Mesa, Arizona, United States +67 more locations

Find Trials by Condition in Arizona

Breast Cancerin Arizona Lung Cancerin Arizona Prostate Cancerin Arizona Colorectal Cancerin Arizona Melanomain Arizona Leukemiain Arizona Lymphomain Arizona Pancreatic Cancerin Arizona Ovarian Cancerin Arizona Brain Cancerin Arizona Diabetes

Data from ClinicalTrials.govTerms

COMPLETEDPhase 333 miles

Efficacy, Safety, Tolerability of Neramexane in Patients With Subjective Tinnitus

NCT00955799

The purpose of this study is to investigate the safety and efficacy of neramexane mesylate in the treatment of subjective tinnitus in comparison to placebo.

Subjective Tinnitus

Merz Pharmaceuticals GmbH455 participantsStarted Sep 2009

Gilbert, Arizona, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +73 more locations

COMPLETEDPhase 135 miles

Safety, Tolerability, Pharmacokinetics of Intravenous RPX2003 (Biapenem) in Healthy Adult Subjects

NCT01702649

RPX2003 (biapenem) is being studied in combination with a beta-lactamase inhibitor to treat bacterial infections, including those due to multi-drug resistant bacteria.

Healthy VolunteersBacterial Infections

Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)36 participantsStarted Aug 2012

Tempe, Arizona, United States

COMPLETEDPhase 335 miles

Study to Evaluate Two Formulations of Carisoprodol in Subjects With Musculoskeletal Spasm of the Lower Back

NCT00671879

The purpose of this study is to determine if two sustained released formulations of carisoprodol are more effective than placebo.

Lower Back Pain

Meda Pharmaceuticals830 participantsStarted Apr 2008

Birmingham, Alabama, United States • Gulf Shores, Alabama, United States • Hueytown, Alabama, United States +70 more locations

TERMINATEDPhase 356 miles

A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (1)

NCT00658008

This is a 10-week trial that evaluates the efficacy and safety of PD 0332334 in subjects, ages from 18 to 65, with generalized anxiety disorder.

Generalized Anxiety Disorder

Pfizer501 participantsStarted Apr 2008

Litchfield Park, Arizona, United States • Costa Mesa, California, United States • Pasadena, California, United States +49 more locations

COMPLETEDPhase 3108 miles

FS VH S/D 500 S-apr in Vascular Surgery

NCT00892957

The purpose of this study was to compare safety and efficacy of FS VH S/D 500 s-apr (FS) versus manual compression in prosthetic expanded polytetrafluoroethylene (ePTFE) graft placement.

Hemostasis in Participants Receiving Peripheral Vascular Expanded Polytetrafluoroethylene (ePTFE) Graft Prostheses

Baxter Healthcare Corporation176 participantsStarted Jul 2009

Birmingham, Alabama, United States • Tucson, Arizona, United States • Fresno, California, United States +19 more locations

COMPLETEDPhase 2108 miles

Fibrin Sealant Vascular Surgery Study

NCT00576420

The purpose of this study is to evaluate the efficacy and safety of Fibrin Sealant, Vapor Heated, Solvent/Detergent-treated with 500 IU/ml thrombin and synthetic aprotinin (FS VH S/D 500 s-apr) for hemostasis in participants receiving prosthetic expanded polytetrafluoroethylene (ePTFE) conduits as compared to a control group treated by manual compression with surgical gauze pads.

Adjunct to Hemostasis in Vascular Surgery (Synthetic Vascular Grafts)

Baxter Healthcare Corporation101 participantsStarted Dec 2007

Birmingham, Alabama, United States • Tucson, Arizona, United States • Long Beach, California, United States +8 more locations

COMPLETED288 miles

Screening for Early Evidence of Diabetes

NCT00614783

This is a pivotal study to determine the accuracy of a new device (SCOUT) in screening persons for pre-diabetes or diabetes. SCOUT will be compared to the standard screening test (Fasting Plasma Glucose), using the Oral Glucose Tolerance Test as the reference standard. SCOUT uses a rapid, noninvasive, light-based technology to measure the concentration of chemicals in the skin called advanced glycation endproducts (AGEs). Several studies have demonstrated that AGEs accumulate in skin faster in individuals with poor control of blood sugar. Persons will be eligible for the study if they are 'at risk' for diabetes based on their age and other risk factors as defined by the American Diabetes Association.

Diabetes Mellitus, Type 2

VeraLight, Inc.3,478 participantsStarted May 2007

Huntsville, Alabama, United States • San Diego, California, United States • San Diego, California, United States +12 more locations

TERMINATEDPhase 3329 miles

A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (2)

NCT00658372

This is a 10-week trial that evaluates the efficacy and safety of PD 0332334 in subjects, ages 18 to 65, with generalized anxiety disorder.

Generalized Anxiety Disorder

Pfizer360 participantsStarted May 2008

Arcadia, California, United States • Costa Mesa, California, United States • Escondido, California, United States +30 more locations

TERMINATEDPhase 2336 miles

Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects

NCT00734435

The purpose of this study is to determine if zonisamide SR will prevent weight gain in schizophrenic subjects who take olanzapine (Zyprexa)

SchizophreniaSchizoaffective DisorderSchizophreniform Disorder

Orexigen Therapeutics, Inc26 participantsStarted Sep 2008

National City, California, United States • Orange, California, United States • San Diego, California, United States +6 more locations

COMPLETEDPhase 3336 miles

A 10-Week Study Evaluating the Efficacy And Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder

NCT00542685

This study will evaluate the efficacy and safety of PD 0332334 for the treatment of generalized anxiety disorder.

Generalized Anxiety Disorder

Pfizer551 participantsStarted Oct 2007

Beverly Hills, California, United States • Encino, California, United States • National City, California, United States +40 more locations

TERMINATEDPhase 2339 miles

A Study to Assess the Safety and Effect of TC-5214 in Patients With Major Depressive Disorder.

NCT01288079

The purpose of this study is to assess the safety and effect of TC-5214 as a single therapy in patients with major depressive disorder who exhibit inadequate response to antidepressants.

Major Depressive Disorder

AstraZeneca145 participantsStarted Feb 2011

Beverly Hills, California, United States • Chino, California, United States • Garden Grove, California, United States +60 more locations

COMPLETEDPhase 4343 miles

Epoprostenol for Injection in Pulmonary Arterial Hypertension - Extension of AC-066A401

NCT01105117

This is an open-label, non-randomized extension to study AC-066A401. The study will assess safety and tolerability of ACT-385781A and Flolan (epoprostenol sodium) while providing a means for continuing treatment after ending participation in study AC-0066A401.

Pulmonary Arterial Hypertension

Actelion2 participantsStarted May 2010

La Jolla, California, United States • Aurora, Colorado, United States • Durham, North Carolina, United States +4 more locations

COMPLETEDPhase 2343 miles

Zonisamide SR Plus Bupropion SR Combination Therapy in Subjects With Obesity

NCT00709371

The purpose of this study is determine if the combination of zonisamide SR and bupropion SR are is more effective than either drug given alone or placebo in the treatment of obesity.

Orexigen Therapeutics, Inc729 participantsStarted Jul 2008

Fairhope, Alabama, United States • La Jolla, California, United States • Denver, Colorado, United States +17 more locations

COMPLETED343 miles

Antimicrobial PK in Infants With Suspected or Confirmed Infection

NCT00491426

The purpose of this protocol is to provide a mechanism for the ongoing collection of blood and urine samples in newborns that will be used to measure levels of antimicrobial products used in the newborn population where there are limited pharmacokinetic data in either premature or term infants.

Duke University450 participantsStarted Jan 2006

La Jolla, California, United States • Washington D.C., District of Columbia, United States • Louisville, Kentucky, United States +3 more locations

COMPLETEDPhase 2374 miles

Study of Lornoxicam or Placebo for Acute Treatment of the Headache of Migraine.

NCT00293657

To determine whether a single dose of intravenous lornoxicam is superior to intravenous placebo for the acute treatment of moderate or severe headache associated with a single migraine attack in patients with a history of migraine. Two-thirds of patients in this study will receive a single dose of intravenous lornoxicam (8mg or 16 mg) and one-third of patients will receive a single dose of an intravenous placebo.

Headache (Migraine)

POZEN150 participantsStarted Dec 2005

Birmingham, Alabama, United States • Mobile, Alabama, United States • Little Rock, Arkansas, United States +20 more locations

COMPLETEDPhase 3388 miles

Trial of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum HIV Transmission

NCT00099359

Giving anti-HIV medications to babies born of HIV positive mothers right after birth can lower the babies' risk of contracting HIV. This study will assess the safety and efficacy of two different combinations of anti-HIV medications compared to a one drug standard regimen in preventing mother to baby transmission. The one drug standard treatment and two combinations to be studied are: 1) zidovudine, 2) zidovudine/nevirapine and 3) zidovudine/lamivudine/nelfinavir.

Disease Transmission, VerticalVertical Human Immunodeficiency Virus TransmissionHIV Infections

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1,735 participantsStarted Feb 2004

Long Beach, California, United States • Gainesville, Florida, United States • Jacksonville, Florida, United States +14 more locations

COMPLETED475 miles

Fibromyalgia Health Outcome Study on Cost of Treatments

NCT00725101

The Real World Examination of Fibromyalgia: Longitudinal Evaluation of Costs and Treatments (REFLECTIONS) Study is a 12-month, prospective observational study that will be utilized in approximately 58 care settings in the United States (US) and Puerto Rico. It is designed to examine treatment patterns and health outcomes of adult participants diagnosed by their physician with fibromyalgia (FM) and who are starting any "new pharmacologic agent" for FM. The primary benefit of this study is enhanced understanding of the disease state of FM and the role that pharmacologic treatment plays, which may help to optimize management of FM. This study will address current gaps in a rapidly growing body of literature on FM.

Eli Lilly and Company1,700 participantsStarted Jun 2008

Hot Springs, Arkansas, United States • Santa Barbara, California, United States • Danbury, Connecticut, United States +55 more locations

COMPLETEDPhase 4552 miles

A Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children

NCT01050582

The purpose of this study is to evaluate the effects of risperidone compared with other atypical antipsychotic drugs on the physical maturity, growth and development of children, and the risk of prolactin-related adverse events (side effects) associated to these drugs.

SchizophreniaBipolar DisorderAutistic Disorder+1 more

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.244 participantsStarted Oct 2009

San Francisco, California, United States • Aurora, Colorado, United States • Altamonte Springs, Florida, United States +25 more locations

PreviousPage 762 of 839Next

in Arizona

Heart Diseasein Arizona